TC BioPharm Announces CAR-T Licensing Deal With UCL Business

UCL academics will assist TCB with development of treatment for leukemia. Clinical programme will see first patients treated in 2018.(PRWeb September 06, 2017)Read the full story at http://www.prweb.com/releases/2017/09/prweb14660669.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news